v3.26.1
EMPLOYEE STOCK PLANS
3 Months Ended
Mar. 31, 2026
Retirement Benefits [Abstract]  
EMPLOYEE STOCK PLANS

NOTE 16 — EMPLOYEE STOCK PLANS

 

Equity Incentive Plans

 

On May 22, 2024, the Company’s Board approved the 2024 Equity Inventive Plan (“2024 Plan”) and Restricted Stock Units (“RSUs”) Agreements. The 2024 Plan and RSUs Agreement authorized the award of stock options, RSUs to employees and directors.

 

The Company recorded $nil and $195,940 stock-based compensation expense in connection with RSUs for three months ended March 31, 2026 and 2025, respectively.

 

As of March 31, 2026, all previously granted restricted stock units (“RSUs”) had vested and there were no outstanding RSUs under the Company’s equity incentive plan.

 

 

MASSIMO GROUP AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

NOTE 16 — EMPLOYEE STOCK PLANS (continued)

 

Options

 

On May 22, 2024, the Company signed a stock option agreement with Mr. David Shan, the then Chief Executive Officer and two other executives of the Company, in connection with the 2024 Plan.

 

As part of the compensation, the Company agrees to grant Mr. Shan options to purchase up to 46,860 common shares under Incentive Stock Option (“ISO”) plan, at an exercise price of $4.268 per share. The options were granted on May 22, 2024, and the options vest at a rate of 23,430 per year for two years, effective on May 22, 2024. The aggregate fair value of the options granted to Mr. Shan was $73,000. The fair value has been estimated using the Black-Scholes pricing model with the following weighted-average assumptions: market value of underlying common shares at time of grant of $3.88; risk free rate of 5.0% and 4.65%; expected term of 5 years; exercise price of the options of $4.268; volatility of 88.8%; and expected future dividends of nil. These options will expire on May 21, 2029.

 

The Company also granted Mr. Shan options to purchase up to 103,140 common shares, at an exercise price of $4.0 per share under a nonqualified stock option (“NSO”) plan. The options were granted on May 22, 2024, and vest at a rate of 51,570 shares per year for two years, effective on May 22, 2024. The aggregate fair value of the options granted to Mr. Shan was $160,000. The fair value has been estimated using the Black-Scholes pricing model with the following weighted-average assumptions: market value of underlying common shares at time of grant of $3.88; risk free rate of 5.0% and 4.65%; expected term of 10 years; exercise price of the options of $4.0; volatility of 88.8%; and expected future dividends of nil. These options will expire on May 21, 2034.

 

The Company also granted two executives options to purchase up to 200,000 common shares, at an exercise price of $4.0 per share under ISO and NSO plans. The options were granted on May 22, 2024, and vest at a rate of 100,000 shares per year for two years, effective on May 22, 2024. The aggregate fair value of the options granted to these two executives was $272,000. The fair value has been estimated using the Black-Scholes pricing model with the following weighted-average assumptions: market value of underlying common shares of $3.88; risk free rate of 5.0% and 4.65%; expected term of 10 years; exercise price of the options of $4.0; volatility of 88.8%; and expected future dividends of nil. These options will expire on May 21, 2034.

 

As of March 31, 2026, intrinsic value of the options is nil.

 

The Company reversed and recorded $29,395 and $90,480 stock-based compensation expense in connection with options for the periods ended March 31, 2026 and 2025, respectively.

 

The following table summarizes the Company’s share option activity:

 

 

  

Number of

Options

  

Weighted Average

Exercise Price

  

Weighted Average Remaining

Life in Years

 
Unvested balance, December 31, 2025   175,000   $4.04    8.06 
Exercisable, December 31, 2025   -   $-    - 
Granted   -    -    - 
Cancelled   -    -    - 
Vested   -    -    - 
Unvested balance, March 31, 2026   175,000   $4.04    7.81 
Exercisable, March 31, 2026   175,000   $-    - 

 

 

MASSIMO GROUP AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)